BOSTON--(BUSINESS WIRE)-- Healthcare investment bank Leerink Swann announced that Franklin M. Stokes has joined the firm’s Investment Banking group as Managing Director. He will be located in Leerink Swann’s San Francisco office and will report directly to Jim Boylan, Senior Managing Director and Head of Investment Banking.

Mr. Stokes brings 16 years of healthcare investment banking experience to Leerink Swann with a number of established relationships in the Tools and Diagnostics and Specialty Pharmaceutical sectors. Frank's primary focus will be to work with the team to establish Leerink Swann as a leader in Life Science Tools and Diagnostics Investment Banking.

“We are pleased to welcome Frank to Leerink Swann,” said Jim Boylan. “Frank brings significant experience, sector knowledge and relationships to the Firm and will play an integral role in augmenting our banking efforts in the life sciences. We look forward to his contributions as we continue to grow Leerink’s investment banking business.”

Frank joins Leerink Swann from Robert W. Baird, & Co where he was the Head of Life Sciences Investment Banking. Previously, Frank spent 12 years at Wachovia Securities specializing in Specialty and Generic Pharmaceuticals. During his career, Frank has led clients in a variety of transactions including public and private equity financings, buy-side and sell-side M&A transactions, hostile takeover defenses and leveraged finance activities.

"Leerink Swann is rapidly emerging as the leading healthcare investment bank serving growth companies globally. The firm differentiates with experienced bankers, unequaled healthcare knowledge and execution excellence. I am excited to join the firm and look forward to growing the business with my partners,“ said Frank Stokes.

About Leerink Swann

Founded in 1995, Leerink Swann is recognized as a leading healthcare investment bank to a broad range of institutional, life sciences, corporate and high-net-worth clients that are positioned to shape the future of healthcare. Leerink Swann's deep domain knowledge provides its clients thoroughly researched insights and perspectives that enable them to make well-informed investment and business decisions. All of its services are enhanced by the expertise of its proprietary MEDACorp network. MEDACorp’s 35,000+ physicians, researchers and healthcare professionals provide unparalleled insights into cutting-edge advances in healthcare. Guided by expert strategy and insight, we offer investment banking, merger and acquisition services, institutional sales and trading, equity research, consulting, and wealth management. Leerink Swann is a member of FINRA/SIPC. For more information, visit www.leerink.com.

CONTACT:

Leerink Swann
Gregg DiPietro, 617-918-4601
Gregg.DiPietro@leerink.com
or
Sard Verbinnen & Co
Chris Kittredge, 212-687-8080
CKittredge@SARDVERB.com

KEYWORDS:   United States  North America  Massachusetts

INDUSTRY KEYWORDS:   Professional Services  Banking  Finance

MEDIA: